Allogene Therapeutics, Inc.ALLONASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank13
3Y CAGR-5.8%
5Y CAGR-22.4%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
-5.8%/yr
vs -45.9%/yr prior
5Y CAGR
-22.4%/yr
Recent acceleration
Acceleration
+40.0pp
Accelerating
Percentile
P13
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $51.69M | -31.3% |
| 2024 | $75.22M | -9.5% |
| 2023 | $83.16M | +34.3% |
| 2022 | $61.90M | -64.3% |
| 2021 | $173.31M | -5.5% |
| 2020 | $183.35M | +4.7% |
| 2019 | $175.13M | -75.7% |
| 2018 | $721.35M | - |
| 2017 | $0.00 | - |